Trial intelligence / Profile preview

Dexmedetomidine nasal spray for preoperative anxiety and anesthesia induction in preschool children

ChiCTR2400089818Phase 4Not yet recruiting

Sponsor
Meishan Municipal People's Hospital
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in preoperative anxiety, Emergence agitation (EA) and postoperative delirium (POD) (2 arms), sponsored by Meishan Municipal People's Hospital. Primary endpoints: Modified Yale Preoperative Anxiety Scale - short form (m-YPAS), Induction Compliance Checklist (ICC) and 1 more. Planned start Sep 2024; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

preoperative anxietyEmergence agitation (EA)postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2400089818.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400089818.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call